Arabidopsis thaliana protein interaction network
Laboratório de Biologia Integrativa e Sistêmica (LaBIS)
Laboratório de Biologia Integrativa e Sistêmica (LaBIS)
Welcome to AtPIN
AtPIN will be upgraded. Please send your suggestions here
AT1G65470 - ( FAS1 (FASCIATA 1) histone binding )
57 Proteins interacs with AT1G65470Locus | Method | FSW ![]() | Cellular Compartment Classification (C3) | Description |
---|---|---|---|---|
AT5G64630![]() ![]() ![]() ![]() | Experimentalcoimmunoprecipitation | FSW = 0.3462
| Class A:nucleus | FAS2 (FASCIATA 2) NUCLEOTIDE BINDING / PROTEIN BINDING |
AT5G59690 | PredictedAffinity Capture-WesternPhenotypic Enhancement | FSW = 0.1201
| Class C:nucleus | HISTONE H4 |
AT3G48750![]() ![]() ![]() ![]() | Predictedbiochemicalinteraction prediction | FSW = 0.0459
| Class C:nucleus | CDC2 (CELL DIVISION CONTROL 2) CYCLIN-DEPENDENT PROTEIN KINASE/ KINASE/ PROTEIN BINDING / PROTEIN KINASE |
AT2G44680![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1017
| Class C:nucleus | CKB4 (CASEIN KINASE II BETA SUBUNIT 4) PROTEIN SERINE/THREONINE KINASE |
AT5G67270![]() ![]() ![]() ![]() | PredictedPhenotypic Suppression | FSW = 0.1432
| Class C:nucleus | ATEB1C (MICROTUBULE END BINDING PROTEIN 1) MICROTUBULE BINDING |
AT3G19840![]() ![]() ![]() ![]() | PredictedAffinity Capture-MS | FSW = 0.0120
| Class C:nucleus | FF DOMAIN-CONTAINING PROTEIN / WW DOMAIN-CONTAINING PROTEIN |
AT3G44530![]() ![]() ![]() ![]() | PredictedSynthetic Lethalitysynthetic growth defectsynthetic growth defectsynthetic growth defectPhenotypic EnhancementPhenotypic Enhancement | FSW = 0.1609
| Class C:nucleus | HIRA (ARABIDOPSIS HOMOLOG OF HISTONE CHAPERONE HIRA) NUCLEOTIDE BINDING / PROTEIN BINDING |
AT4G38130![]() ![]() ![]() ![]() | PredictedSynthetic RescueShared biological functionCo-expression | FSW = 0.0588
| Class C:nucleus | HD1 (HISTONE DEACETYLASE 1) BASAL TRANSCRIPTION REPRESSOR/ HISTONE DEACETYLASE/ PROTEIN BINDING |
AT3G06720![]() ![]() ![]() ![]() | PredictedAffinity Capture-MSinteraction prediction | FSW = 0.0169
| Class C:nucleus | IMPA-1 (IMPORTIN ALPHA ISOFORM 1) BINDING / PROTEIN TRANSPORTER |
AT1G04510![]() ![]() ![]() ![]() | PredictedPhenotypic EnhancementCo-expression | FSW = 0.0159
| Class C:nucleus | TRANSDUCIN FAMILY PROTEIN / WD-40 REPEAT FAMILY PROTEIN |
AT2G29570![]() ![]() ![]() ![]() | Predictedin vitrotwo hybrid | FSW = 0.0980
| Class C:nucleus | PCNA2 (PROLIFERATING CELL NUCLEAR ANTIGEN 2) DNA BINDING / DNA POLYMERASE PROCESSIVITY FACTOR |
AT5G17690![]() ![]() ![]() ![]() | Predictedtwo hybridin vitroin vivoin vitroin vivotwo hybridAffinity Capture-Western | FSW = 0.0141
| Class C:nucleus | TFL2 (TERMINAL FLOWER 2) DNA BINDING / METHYLATED HISTONE RESIDUE BINDING |
AT1G07370![]() ![]() ![]() ![]() | Predictedsynthetic growth defectPhenotypic SuppressionPhenotypic EnhancementCo-expression | FSW = 0.2228
| Class C:nucleus | PCNA1 (PROLIFERATING CELLULAR NUCLEAR ANTIGEN) DNA BINDING / DNA POLYMERASE PROCESSIVITY FACTOR/ PROTEIN BINDING |
AT2G27470![]() ![]() ![]() ![]() | PredictedReconstituted ComplexCo-expression | FSW = 0.2055
| Class C:nucleus | NF-YB11 (NUCLEAR FACTOR Y SUBUNIT B11) TRANSCRIPTION FACTOR |
AT3G19210![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.2422
| Class C:nucleus | ATRAD54 (ARABIDOPSIS HOMOLOG OF RAD54) ATP BINDING / DNA BINDING / HELICASE/ NUCLEIC ACID BINDING |
AT2G13370![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1355
| Class C:nucleus | CHR5 (CHROMATIN REMODELING 5) ATP BINDING / DNA BINDING / CHROMATIN BINDING / HELICASE/ NUCLEIC ACID BINDING |
AT5G08630![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1209
| Class C:nucleus | DDT DOMAIN-CONTAINING PROTEIN |
AT2G03870![]() ![]() ![]() ![]() | PredictedPhenotypic Suppression | FSW = 0.1692
| Class C:nucleus | SMALL NUCLEAR RIBONUCLEOPROTEIN PUTATIVE / SNRNP PUTATIVE / SM PROTEIN PUTATIVE |
AT1G07660 | PredictedAffinity Capture-Western | FSW = 0.0544
| Unknown | HISTONE H4 |
AT4G01370![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.0444
| Unknown | ATMPK4 (ARABIDOPSIS THALIANA MAP KINASE 4) MAP KINASE/ KINASE |
AT3G02520![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.0972
| Unknown | GRF7 (GENERAL REGULATORY FACTOR 7) PROTEIN BINDING / PROTEIN PHOSPHORYLATED AMINO ACID BINDING |
AT2G33340![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.0177
| Unknown | NUCLEOTIDE BINDING / UBIQUITIN-PROTEIN LIGASE |
AT5G63110![]() ![]() ![]() ![]() | PredictedSynthetic Rescue | FSW = 0.1011
| Unknown | HDA6 (HISTONE DEACETYLASE 6) HISTONE DEACETYLASE |
AT5G53480![]() ![]() ![]() ![]() | PredictedAffinity Capture-MSinteraction prediction | FSW = 0.0073
| Unknown | IMPORTIN BETA-2 PUTATIVE |
AT3G18524![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1485
| Unknown | MSH2 (MUTS HOMOLOG 2) ATP BINDING / DAMAGED DNA BINDING / MISMATCHED DNA BINDING / PROTEIN BINDING |
AT5G41150![]() ![]() ![]() ![]() | PredictedPhenotypic EnhancementPhenotypic Enhancement | FSW = 0.1488
| Unknown | UVH1 (ULTRAVIOLET HYPERSENSITIVE 1) SINGLE-STRANDED DNA SPECIFIC ENDODEOXYRIBONUCLEASE |
AT2G31970![]() ![]() ![]() ![]() | PredictedSynthetic Lethalitysynthetic growth defectPhenotypic Enhancementinteraction prediction | FSW = 0.1793
| Unknown | RAD50 ATP BINDING / NUCLEASE/ ZINC ION BINDING |
AT5G57450![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.2206
| Unknown | XRCC3 ATP BINDING / DAMAGED DNA BINDING / PROTEIN BINDING / SINGLE-STRANDED DNA BINDING |
AT5G66130![]() ![]() ![]() ![]() | PredictedPhenotypic EnhancementPhenotypic Enhancement | FSW = 0.2200
| Unknown | ATRAD17 (ARABIDOPSIS THALIANA RADIATION SENSITIVE) |
AT3G28730![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1496
| Unknown | ATHMG (ARABIDOPSIS THALIANA HIGH MOBILITY GROUP) TRANSCRIPTION FACTOR |
AT3G61140![]() ![]() ![]() ![]() | PredictedShared biological functionCo-expression | FSW = 0.0227
| Unknown | FUS6 (FUSCA 6) |
AT5G54260![]() ![]() ![]() ![]() | Predictedsynthetic growth defect | FSW = 0.2051
| Unknown | MRE11 (MEIOTIC RECOMBINATION 11) ENDONUCLEASE/ EXONUCLEASE/ HYDROLASE/ MANGANESE ION BINDING / PROTEIN SERINE/THREONINE PHOSPHATASE |
AT5G40820![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1642
| Unknown | ATRAD3 BINDING / INOSITOL OR PHOSPHATIDYLINOSITOL KINASE/ PHOSPHOTRANSFERASE ALCOHOL GROUP AS ACCEPTOR / PROTEIN SERINE/THREONINE KINASE |
AT5G20850![]() ![]() ![]() ![]() | PredictedPhenotypic EnhancementPhenotypic Enhancement | FSW = 0.1802
| Unknown | ATRAD51 ATP BINDING / DNA BINDING / DNA-DEPENDENT ATPASE/ DAMAGED DNA BINDING / NUCLEOSIDE-TRIPHOSPHATASE/ NUCLEOTIDE BINDING / PROTEIN BINDING / SEQUENCE-SPECIFIC DNA BINDING |
AT3G05740![]() ![]() ![]() ![]() | Predictedfar western blottingAffinity Capture-Westerntwo hybrid | FSW = 0.1343
| Unknown | RECQI1 (ARABIDOPSIS RECQ HELICASE L1) ATP BINDING / ATP-DEPENDENT HELICASE/ HELICASE/ NUCLEIC ACID BINDING |
AT5G38110![]() ![]() ![]() ![]() | Predictedin vivoAffinity Capture-MS | FSW = 0.0111
| Unknown | ASF1B (ANTI- SILENCING FUNCTION 1B) |
AT1G04730 | Predictedsynthetic growth defectCo-expression | FSW = 0.1983
| Unknown | AAA-TYPE ATPASE FAMILY PROTEIN |
AT1G06790![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.0038
| Unknown | RNA POLYMERASE RPB7 N-TERMINAL DOMAIN-CONTAINING PROTEIN |
AT1G29150![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.0662
| Unknown | ATS9 (ARABIDOPSIS NON-ATPASE SUBUNIT 9) |
AT1G10930![]() ![]() ![]() ![]() | PredictedPhenotypic EnhancementPhenotypic Enhancement | FSW = 0.1731
| Unknown | RECQ4A ATP BINDING / ATP-DEPENDENT HELICASE/ HELICASE/ NUCLEIC ACID BINDING |
AT1G66740![]() ![]() ![]() ![]() | PredictedSynthetic RescueSynthetic Lethalitysynthetic growth defectsynthetic growth defectsynthetic growth defectPhenotypic EnhancementPhenotypic Enhancementsynthetic growth defectsynthetic growth defectPhenotypic EnhancementPhenotypic Enhancement | FSW = 0.1996
| Unknown | SGA2 |
AT2G18290![]() ![]() ![]() ![]() | Predictedsynthetic growth defect | FSW = 0.0718
| Unknown | ANAPHASE-PROMOTING COMPLEX SUBUNIT 10 FAMILY / APC10 FAMILY |
AT2G20000![]() ![]() ![]() ![]() | Predictedtwo hybrid | FSW = 0.0409
| Unknown | HBT (HOBBIT) BINDING |
AT2G44580![]() ![]() ![]() ![]() | Predictedsynthetic growth defect | FSW = 0.1951
| Unknown | PROTEIN BINDING / ZINC ION BINDING |
AT3G42660![]() ![]() ![]() ![]() | PredictedSynthetic Lethalitysynthetic growth defectinteraction predictionCo-expression | FSW = 0.1951
| Unknown | NUCLEOTIDE BINDING |
AT4G25120 | Predictedtwo hybrid | FSW = 0.1509
| Unknown | ATP BINDING / ATP-DEPENDENT DNA HELICASE/ DNA BINDING / HYDROLASE |
AT5G26680![]() ![]() ![]() ![]() | PredictedSynthetic Lethalitysynthetic growth defect | FSW = 0.2418
| Unknown | ENDONUCLEASE PUTATIVE |
AT3G10070![]() ![]() ![]() ![]() | PredictedPhenotypic Suppression | FSW = 0.0499
| Unknown | TAF12 (TBP-ASSOCIATED FACTOR 12) DNA BINDING / TRANSCRIPTION INITIATION FACTOR |
AT5G09230![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.0279
| Unknown | SRT2 (SIRTUIN 2) DNA BINDING / NAD OR NADH BINDING / NAD-DEPENDENT HISTONE DEACETYLASE/ ZINC ION BINDING |
AT5G10390 | PredictedPhenotypic Enhancement | FSW = 0.1417
| Unknown | HISTONE H3 |
AT5G10400 | PredictedAffinity Capture-WesternPhenotypic Enhancement | FSW = 0.1705
| Unknown | HISTONE H3 |
AT5G27740![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.2374
| Unknown | EMB2775 (EMBRYO DEFECTIVE 2775) DNA BINDING / NUCLEOSIDE-TRIPHOSPHATASE/ NUCLEOTIDE BINDING |
AT5G41880![]() ![]() ![]() ![]() | PredictedPhenotypic Suppression | FSW = 0.1355
| Unknown | POLA3 DNA PRIMASE |
AT1G02690![]() ![]() ![]() ![]() | PredictedAffinity Capture-MSCo-expression | FSW = 0.0183
| Unknown | IMPA-6 (IMPORTIN ALPHA ISOFORM 6) BINDING / PROTEIN TRANSPORTER |
AT1G09200 | PredictedAffinity Capture-WesternCo-expression | FSW = 0.1247
| Unknown | HISTONE H3 |
AT1G67500![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1306
| Unknown | ATREV3 (ARABIDOPSIS THALIANA RECOVERY PROTEIN 3) DNA BINDING / DNA-DIRECTED DNA POLYMERASE |
AT1G14400![]() ![]() ![]() ![]() | PredictedPhenotypic Enhancement | FSW = 0.1187
| Unknown | UBC1 (UBIQUITIN CARRIER PROTEIN 1) UBIQUITIN-PROTEIN LIGASE |
Downloads
Quick help
Experimental: This means that the indicated PPI was experimentally demonstrated using Arabidopsis thaliana proteins as model of study. The experiment indicated links to the publication of which this interaction was annotated from
Predicted: The indicated PPI was proposed based on ortholgs studies. The experiment indicated links to the publication of the orthologous PPI was annotated from
FSW
FSW is the Functional Similarity Weight. It represents the proportion of interaction partners that two proteins have in commonLearn more - FSWeight top ranked cut offs
C3
Class A: The PPI is a direct evidence (experimental), the subcellular location was experimentally demonstrated and both, target and source, were indicated as expressed in same cellular compartment
Class B: The PPI is a direct evidence (experimental), the subcellular location was experimentally demonstrated but both, target and source, were indicated as expressed in different cellular compartment
Class C: Same as Class A but the PPI is predicted
Class D: Same as Class A but subcellular location was predicted. P(exp|pred) indicates the probability of this particular predicted location be experimentally demonstrated given all data available on AtPINDB
Unknown: There is no available data to calculate the C3 or the data does not fit onto any class previously described
PEP
PEP is the posterior probability of this particular PPI be experimentally demonstrated once it was predicted. For this release p = 0.0030. If they share same cell compartment p = 0.0029Learn more
How to cite
If you find AtPIN interesting and want to use it in your work please cite usAtPIN: Arabidopsis thaliana Protein Interaction Network
Marcelo M Brandao, Luiza L Dantas and Marcio C Silva-Filho
BMC Bioinformatics 2009, 10:454DOI:1471-2105/10/454
Marcelo M Brandao, Luiza L Dantas and Marcio C Silva-Filho
BMC Bioinformatics 2009, 10:454DOI:1471-2105/10/454